Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Chronic kidney disease
•
Nephrology
•
Interventional Nephrology
What is the optimal number of days to hold apixaban prior to a kidney biopsy or tunneled dialysis catheter placement?
Related Questions
Would you stop an ACE inhibitor/ARB or instead initiate a potassium binder to manage hyperkalemia in a patient with proteinuric CKD stage 5 who is on an ACEi/ARB?
How do you recommend incorporating B-lines on lung POCUS as part of evaluating a patient's volume status?
What is your approach to patients with chronic kidney disease who are found to have pelviectasis without hydronephrosis on renal ultrasound imaging?
How do you approach hematuria in a patient with diabetic nephropathy?
How would you approach management of retroperitoneal fibrosis causing ureteral compression that has already caused irreversible loss of kidney function?
Under what circumstances would you hold an ACE inhibitor or ARB prior to surgery in a patient with CKD?
Is there a role for monitoring PTH levels in patients with advanced chronic kidney disease who are receiving denosumab to assess for adynamic bone disease?
Is there a BMI cutoff for which you would refer a patient needing a native kidney biopsy to interventional radiology?
What are your top takeaways from ASN 2024?
How long do you monitor proteinuria after starting an SGLT-2 inhibitor before considering adding another medication if proteinuria is not at goal?
